ASPIRIN AND CAFFEINE

ASPIRIN AND CAFFEINE was reported 21130 times

ASPIRIN AND CAFFEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MACRODACTYLY 1 0.1000
1 LARGE INTESTINAL STRICTURE 1 0.0345
2 SARS-COV-2 TEST FALSE POSITIVE 1 0.0227
3 NECROSIS OF ARTERY 1 0.0222
4 DIABETIC MICROANGIOPATHY 1 0.0156
5 TYPICAL AURA WITHOUT HEADACHE 1 0.0102
6 CHEST WALL TUMOUR 1 0.0083
7 CHRONIC HEPATITIS C 2 0.0051
8 PARANASAL SINUS HYPOSECRETION 1 0.0040
9 FUNGAL PHARYNGITIS 1 0.0040
10 LACK OF SATIETY 1 0.0038
11 NASAL NEOPLASM 1 0.0037
12 HYPERTENSIVE CARDIOMYOPATHY 1 0.0036
13 GASTROINTESTINAL ARTERIOVENOUS MALFORMATION 1 0.0034
14 CATHETER SITE HAEMATOMA 1 0.0034
15 HEPATITIS ALCOHOLIC 1 0.0031
16 NEUROMYELITIS OPTICA 1 0.0030
17 BLOOD VISCOSITY DECREASED 1 0.0030
18 ESSENTIAL THROMBOCYTHAEMIA 1 0.0027
19 MYOCARDIAL OEDEMA 1 0.0025
20 ACOUSTIC NEUROMA 1 0.0024
21 DUCTUS ARTERIOSUS STENOSIS FOETAL 1 0.0023
22 FACIAL NERVE DISORDER 1 0.0023
23 HEPATIC ENZYME DECREASED 1 0.0022
24 GALLBLADDER CHOLESTEROLOSIS 1 0.0022
25 ABDOMINAL INJURY 1 0.0019
26 TRANSVERSE SINUS THROMBOSIS 1 0.0019
27 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 1 0.0019
28 FRACTURE PAIN 1 0.0019
29 LIFE SUPPORT 1 0.0018
30 GALLBLADDER NON-FUNCTIONING 1 0.0018
31 NEURODEGENERATIVE DISORDER 1 0.0016
32 GASTRIC ULCER PERFORATION 2 0.0016
33 GASTROINTESTINAL EROSION 1 0.0016
34 GALLBLADDER PAIN 1 0.0015
35 PEPTIC ULCER HAEMORRHAGE 1 0.0014
36 SKIN NEOPLASM EXCISION 1 0.0013
37 BREAST CALCIFICATIONS 1 0.0013
38 SINUSITIS FUNGAL 1 0.0012
39 PYLORIC STENOSIS 1 0.0012
40 CLEFT LIP 1 0.0011
41 CEREBELLAR ATROPHY 1 0.0011
42 RIGHT VENTRICULAR HYPERTROPHY 1 0.0011
43 HAEMORRHAGIC ARTERIOVENOUS MALFORMATION 1 0.0011
44 VENOUS INJURY 1 0.0011
45 TONGUE INJURY 1 0.0011
46 SLEEP-RELATED EATING DISORDER 1 0.0011
47 SHOULDER PAIN 1 0.0010
48 RECTAL POLYP 1 0.0010
49 BUTTERFLY RASH 1 0.0010
50 GASTROINTESTINAL ULCER 2 0.0009
51 SLOW SPEECH 2 0.0008
52 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
53 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
54 GASTRIC PERFORATION 2 0.0007
55 CONNECTIVE TISSUE DISORDER 1 0.0007
56 HAEMORRHAGIC ANAEMIA 3 0.0007
57 GENERALISED ANXIETY DISORDER 1 0.0007
58 COCCYDYNIA 1 0.0007
59 GASTRITIS HAEMORRHAGIC 1 0.0007
60 MYELITIS 1 0.0006
61 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
62 SEBORRHOEIC DERMATITIS 1 0.0006
63 ULCER HAEMORRHAGE 4 0.0006
64 LAZINESS 1 0.0006
65 SENSITIVITY OF TEETH 1 0.0006
66 KYPHOSIS 1 0.0006
67 ESSENTIAL HYPERTENSION 1 0.0005
68 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
69 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
70 INTENTIONAL MISUSE 1 0.0005
71 GALLBLADDER INJURY 1 0.0005
72 NASAL SEPTUM DEVIATION 1 0.0005
73 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
74 PHYSICAL ASSAULT 1 0.0005
75 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
76 CORNEAL DISORDER 1 0.0005
77 LIMB MASS 1 0.0005
78 MIDDLE EAR EFFUSION 1 0.0005
79 BRAIN OPERATION 1 0.0004
80 ISCHAEMIA 2 0.0004
81 GASTRIC HAEMORRHAGE 5 0.0004
82 GASTRITIS EROSIVE 2 0.0004
83 PANCREATITIS CHRONIC 1 0.0004
84 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
85 GASTRIC ULCER 8 0.0004
86 CARTILAGE INJURY 1 0.0004
87 ANEURYSM 2 0.0004
88 INCREASED BRONCHIAL SECRETION 1 0.0004
89 VENTRICULAR DYSFUNCTION 1 0.0004
90 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
91 LUNG OPACITY 1 0.0004
92 ULCER 6 0.0004
93 ALCOHOL ABUSE 1 0.0004
94 ABDOMINAL MASS 1 0.0004
95 CHONDROPATHY 1 0.0004
96 HYPOMENORRHOEA 1 0.0004
97 PLEURITIC PAIN 1 0.0004
98 GASTRIC ULCER HAEMORRHAGE 2 0.0004
99 DUODENAL ULCER HAEMORRHAGE 1 0.0003
100 LIP PAIN 1 0.0003
101 DEVICE POWER SOURCE ISSUE 1 0.0003
102 BONE MARROW DISORDER 1 0.0003
103 INJECTION SITE VESICLES 2 0.0003
104 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
105 IRITIS 1 0.0003
106 DUODENITIS 1 0.0003
107 IRON DEFICIENCY ANAEMIA 3 0.0003
108 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
109 POSTURE ABNORMAL 1 0.0003
110 BACTERIAL SEPSIS 1 0.0003
111 SOMNAMBULISM 2 0.0003
112 PEPTIC ULCER 1 0.0003
113 CHOLECYSTITIS CHRONIC 2 0.0003
114 POLYMENORRHOEA 1 0.0003
115 BODY HEIGHT DECREASED 3 0.0003
116 APPARENT DEATH 1 0.0003
117 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
118 RECTAL DISCHARGE 1 0.0003
119 ALCOHOL USE 1 0.0003
120 HYPOPHOSPHATAEMIA 2 0.0003
121 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
122 INTERNAL HAEMORRHAGE 3 0.0003
123 PARANASAL SINUS HYPERSECRETION 1 0.0003
124 COMMUNICATION DISORDER 1 0.0003
125 THYROID MASS 1 0.0003
126 OESOPHAGEAL DISORDER 1 0.0003
127 VENOUS THROMBOSIS 1 0.0003
128 CEREBRAL ATROPHY 1 0.0003
129 HYPERPHAGIA 1 0.0003
130 INTRACRANIAL ANEURYSM 1 0.0002
131 VITAMIN B12 DEFICIENCY 1 0.0002
132 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
133 ALCOHOLISM 1 0.0002
134 TOOTH INJURY 1 0.0002
135 BONE CANCER 1 0.0002
136 DYSPHEMIA 1 0.0002
137 SINUS CONGESTION 3 0.0002
138 PAPILLOEDEMA 1 0.0002
139 EYE OPERATION 1 0.0002
140 RENAL FUNCTION TEST ABNORMAL 1 0.0002
141 SKIN TIGHTNESS 1 0.0002
142 HYPOVOLAEMIC SHOCK 1 0.0002
143 HEPATOMEGALY 2 0.0002
144 HYPERVOLAEMIA 1 0.0002
145 AMMONIA INCREASED 1 0.0002
146 PRODUCT COLOUR ISSUE 1 0.0002
147 ANKLE FRACTURE 3 0.0002
148 ANHEDONIA 5 0.0002
149 BRUXISM 1 0.0002
150 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
151 OESOPHAGITIS 2 0.0002
152 CHOKING SENSATION 1 0.0002
153 DENTAL CARIES 2 0.0002
154 COAGULOPATHY 3 0.0002
155 NERVE INJURY 2 0.0002
156 INTRACRANIAL PRESSURE INCREASED 1 0.0002
157 ANGIOPATHY 1 0.0002
158 COLECTOMY 1 0.0002
159 EXERCISE TOLERANCE DECREASED 1 0.0002
160 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
161 RALES 1 0.0002
162 CHOLECYSTITIS 2 0.0002
163 TYPE 1 DIABETES MELLITUS 1 0.0002
164 END STAGE RENAL DISEASE 3 0.0002
165 TENSION 1 0.0002
166 PRE-EXISTING CONDITION IMPROVED 1 0.0002
167 INJECTION SITE DISCOLOURATION 2 0.0002
168 NASAL DRYNESS 1 0.0002
169 POISONING 2 0.0002
170 PHOTOPSIA 1 0.0002
171 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
172 WALKING AID USER 1 0.0002
173 SINUS DISORDER 3 0.0002
174 EYE HAEMORRHAGE 2 0.0001
175 POST-TRAUMATIC STRESS DISORDER 1 0.0001
176 QUALITY OF LIFE DECREASED 2 0.0001
177 BREAST MASS 1 0.0001
178 ACUTE HEPATIC FAILURE 2 0.0001
179 BLOOD TESTOSTERONE DECREASED 1 0.0001
180 ECCHYMOSIS 1 0.0001
181 JOINT EFFUSION 1 0.0001
182 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
183 THERMAL BURN 1 0.0001
184 DIVERTICULUM 1 0.0001
185 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
186 VISUAL FIELD DEFECT 1 0.0001
187 GASTROENTERITIS 2 0.0001
188 MOUTH HAEMORRHAGE 1 0.0001
189 SENSITIVE SKIN 1 0.0001
190 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
191 FEELING DRUNK 1 0.0001
192 HYDRONEPHROSIS 1 0.0001
193 GENERAL SYMPTOM 1 0.0001
194 DRUG DISPENSING ERROR 2 0.0001
195 RENAL FAILURE CHRONIC 1 0.0001
196 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
197 APHTHOUS ULCER 1 0.0001
198 PULMONARY HAEMORRHAGE 1 0.0001
199 DEPENDENCE 7 0.0001
200 FURUNCLE 1 0.0001
201 TRICUSPID VALVE INCOMPETENCE 1 0.0001
202 STENT PLACEMENT 1 0.0001
203 MUSCLE DISORDER 1 0.0001
204 SHOCK HAEMORRHAGIC 1 0.0001
205 POLYURIA 1 0.0001
206 ABNORMAL FAECES 1 0.0001
207 HAEMATEMESIS 3 0.0001
208 BLOOD MAGNESIUM DECREASED 1 0.0001
209 MUSCLE STRAIN 1 0.0001
210 GROIN PAIN 1 0.0001
211 FACIAL PAIN 1 0.0001
212 FEAR 3 0.0001
213 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
214 ACCIDENTAL OVERDOSE 4 0.0001
215 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
216 GRAND MAL CONVULSION 1 0.0001
217 HEPATIC CIRRHOSIS 2 0.0001
218 COLITIS 4 0.0001
219 CHRONIC KIDNEY DISEASE 8 0.0001
220 PRODUCT PACKAGING ISSUE 1 0.0001
221 SLEEP APNOEA SYNDROME 2 0.0001
222 VITAMIN D DEFICIENCY 1 0.0001
223 HAEMORRHOIDS 2 0.0001
224 MENORRHAGIA 2 0.0001
225 KNEE OPERATION 1 0.0001
226 HOSPICE CARE 1 0.0001
227 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
228 BRAIN INJURY 1 0.0001
229 DRY THROAT 1 0.0001
230 INITIAL INSOMNIA 1 0.0001
231 EAR DISCOMFORT 1 0.0001
232 TEMPERATURE INTOLERANCE 1 0.0001
233 EYE DISCHARGE 1 0.0001
234 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
235 ROAD TRAFFIC ACCIDENT 4 0.0001
236 HALLUCINATION, VISUAL 2 0.0001
237 JOINT DISLOCATION 1 0.0001
238 RENAL PAIN 1 0.0001
239 RECTAL HAEMORRHAGE 4 0.0001
240 HYPOACUSIS 4 0.0001
241 DECREASED ACTIVITY 1 0.0001
242 FAECES DISCOLOURED 2 0.0001
243 SKIN LACERATION 1 0.0001
244 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
245 EYE DISORDER 3 0.0001
246 GASTROINTESTINAL PAIN 1 0.0001
247 INJECTION SITE NODULE 1 0.0001
248 STEVENS-JOHNSON SYNDROME 2 0.0001
249 URINARY RETENTION 3 0.0001
250 MALNUTRITION 1 0.0001
251 RASH PAPULAR 2 0.0001
252 PANCREATITIS ACUTE 2 0.0001
253 FISTULA 1 0.0001
254 ANGER 3 0.0001
255 MYOCARDIAL ISCHAEMIA 1 0.0001
256 CHOLECYSTECTOMY 1 0.0001
257 MUSCLE TWITCHING 2 0.0001
258 METASTASES TO LUNG 1 0.0001
259 SPLENOMEGALY 1 0.0001
260 BLOOD IRON DECREASED 1 0.0001
261 ATAXIA 1 0.0001
262 MIGRAINE 8 0.0001
263 WRIST FRACTURE 1 0.0001
264 DRUG EFFECT INCOMPLETE 3 0.0001
265 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
266 SCHIZOPHRENIA 1 0.0001
267 ENCEPHALOPATHY 2 0.0001
268 MUSCLE SPASTICITY 1 0.0001
269 CARDIOMEGALY 1 0.0001
270 TENDON RUPTURE 1 0.0001
271 GENERALISED OEDEMA 1 0.0001
272 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
273 NODULE 1 0.0001
274 IMMUNE SYSTEM DISORDER 1 0.0001
275 TOOTH INFECTION 1 0.0001
276 DYSMENORRHOEA 1 0.0001
277 ADVERSE REACTION 1 0.0001
278 HAIR TEXTURE ABNORMAL 1 0.0001
279 MENSTRUATION IRREGULAR 2 0.0001
280 THROAT TIGHTNESS 2 0.0001
281 TACHYPNOEA 1 0.0001
282 DEMENTIA 2 0.0001
283 MASS 1 0.0001
284 CARPAL TUNNEL SYNDROME 1 0.0001
285 SEASONAL ALLERGY 1 0.0001
286 DIALYSIS 1 0.0001
287 SINUS TACHYCARDIA 1 0.0001
288 INJECTION SITE HAEMATOMA 1 0.0001
289 COLON CANCER 1 0.0001
290 HAEMORRHAGE INTRACRANIAL 1 0.0001
291 ECONOMIC PROBLEM 1 0.0001
292 TINNITUS 3 0.0001
293 PHARYNGEAL OEDEMA 1 0.0001
294 THYROID DISORDER 1 0.0001
295 LYMPHOMA 1 0.0001
296 MUSCULOSKELETAL CHEST PAIN 1 0.0001
297 RENAL DISORDER 3 0.0001
298 BLOOD CHOLESTEROL INCREASED 3 0.0001
299 MENINGIOMA 1 0.0001
300 RASH ERYTHEMATOUS 3 0.0001
301 SCIATICA 1 0.0001
302 LOSS OF CONSCIOUSNESS 8 0.0001
303 HYPOGLYCAEMIA 3 0.0001
304 BLOOD POTASSIUM INCREASED 1 0.0001
305 CHOLELITHIASIS 2 0.0001
306 PHOTOSENSITIVITY REACTION 1 0.0001
307 LIP SWELLING 2 0.0001
308 PERICARDITIS 1 0.0001
309 CIRCULATORY COLLAPSE 1 0.0001
310 FEELING ABNORMAL 14 0.0001
311 SCAR 1 0.0001
312 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
313 NIGHTMARE 2 0.0001
314 ANAEMIA 11 0.0001
315 RASH MACULAR 2 0.0001
316 EOSINOPHILIA 1 0.0001
317 INJURY 4 0.0001
318 LYMPHOCYTE COUNT DECREASED 1 0.0001
319 LYMPHADENOPATHY 2 0.0001
320 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
321 TACHYCARDIA 5 0.0001
322 GALLBLADDER DISORDER 1 0.0001
323 BACK PAIN 13 0.0001
324 GOUT 1 0.0001
325 GASTROENTERITIS VIRAL 1 0.0001
326 RASH PRURITIC 3 0.0001
327 TOOTHACHE 1 0.0001
328 OSTEOMYELITIS 1 0.0001
329 CRYING 2 0.0001
330 BONE DISORDER 1 0.0001
331 PANIC ATTACK 2 0.0001
332 HAEMATOCHEZIA 3 0.0001
333 HEPATIC STEATOSIS 1 0.0001
334 THINKING ABNORMAL 1 0.0001
335 OXYGEN SATURATION DECREASED 3 0.0001
336 DYSARTHRIA 2 0.0001
337 FOOT FRACTURE 1 0.0001
338 PROTEINURIA 1 0.0001
339 HERPES ZOSTER 3 0.0001
340 ACUTE RESPIRATORY FAILURE 1 0.0001
341 EAR PAIN 1 0.0001
342 DYSPHONIA 3 0.0001
343 CHOKING 1 0.0001
344 ORAL HERPES 1 0.0001
345 SKIN FISSURES 1 0.0001
346 KIDNEY INFECTION 1 0.0001
347 HAEMATOCRIT DECREASED 1 0.0001
348 BLOOD PRESSURE ABNORMAL 1 0.0001
349 PREGNANCY 1 0.0000
350 CYTOKINE RELEASE SYNDROME 1 0.0000
351 FEEDING DISORDER 1 0.0000
352 BLINDNESS 2 0.0000
353 BODY TEMPERATURE INCREASED 1 0.0000
354 RIB FRACTURE 1 0.0000
355 INJECTION SITE WARMTH 1 0.0000
356 CHEST PAIN 9 0.0000
357 HAEMORRHAGE 5 0.0000
358 WITHDRAWAL SYNDROME 2 0.0000
359 OSTEOARTHRITIS 2 0.0000
360 JOINT INJURY 1 0.0000
361 IRRITABLE BOWEL SYNDROME 1 0.0000
362 POOR QUALITY SLEEP 1 0.0000
363 BALANCE DISORDER 4 0.0000
364 PRURITUS GENERALISED 1 0.0000
365 AMNESIA 3 0.0000
366 MELAENA 1 0.0000
367 RENAL FAILURE 6 0.0000
368 TRANSAMINASES INCREASED 1 0.0000
369 INJECTION SITE PRURITUS 3 0.0000
370 HEADACHE 28 0.0000
371 SNEEZING 1 0.0000
372 THROAT IRRITATION 2 0.0000
373 DRUG DEPENDENCE 7 0.0000
374 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
375 DYSPHAGIA 4 0.0000
376 PULMONARY EMBOLISM 4 0.0000
377 MOBILITY DECREASED 3 0.0000
378 HEPATIC CANCER 1 0.0000
379 TOXICITY TO VARIOUS AGENTS 7 0.0000
380 LOCALISED INFECTION 1 0.0000
381 EMOTIONAL DISTRESS 5 0.0000
382 MENTAL IMPAIRMENT 1 0.0000
383 INJECTION SITE URTICARIA 1 0.0000
384 INJECTION SITE ERYTHEMA 5 0.0000
385 CARDIOVASCULAR DISORDER 1 0.0000
386 INJECTION SITE SWELLING 3 0.0000
387 INJECTION SITE PAIN 12 0.0000
388 HEPATITIS 1 0.0000
389 CHEST DISCOMFORT 4 0.0000
390 ABDOMINAL PAIN UPPER 8 0.0000
391 UNRESPONSIVE TO STIMULI 1 0.0000
392 ABDOMINAL PAIN 9 0.0000
393 SKIN ULCER 1 0.0000
394 HAEMATOMA 1 0.0000
395 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
396 NERVOUSNESS 2 0.0000
397 DEAFNESS 1 0.0000
398 SPEECH DISORDER 2 0.0000
399 GASTRITIS 1 0.0000
400 HYPERTENSION 8 0.0000
401 PAIN 23 0.0000
402 PAIN OF SKIN 1 0.0000
403 DRUG EFFECT DECREASED 2 0.0000
404 FREQUENT BOWEL MOVEMENTS 1 0.0000
405 LIMB INJURY 1 0.0000
406 PRODUCT QUALITY ISSUE 5 0.0000
407 INFLUENZA LIKE ILLNESS 3 0.0000
408 MEMORY IMPAIRMENT 5 0.0000
409 RESPIRATORY ARREST 1 0.0000
410 ABNORMAL DREAMS 1 0.0000
411 ARTHRALGIA 15 0.0000
412 PROCEDURAL PAIN 1 0.0000
413 DRUG ABUSE 3 0.0000
414 MENTAL STATUS CHANGES 1 0.0000
415 HAEMOPTYSIS 1 0.0000
416 NECK PAIN 2 0.0000
417 WOUND 1 0.0000
418 ABDOMINAL DISCOMFORT 6 0.0000
419 WEIGHT INCREASED 8 0.0000
420 HYPONATRAEMIA 2 0.0000
421 CEREBROVASCULAR ACCIDENT 6 0.0000
422 PAIN IN JAW 1 0.0000
423 FLATULENCE 2 0.0000
424 DEPRESSION 8 0.0000
425 CONVULSION 2 0.0000
426 ANGINA PECTORIS 1 0.0000
427 LIVER FUNCTION TEST ABNORMAL 1 0.0000
428 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
429 NASAL CONGESTION 2 0.0000
430 ACUTE MYOCARDIAL INFARCTION 1 0.0000
431 LABORATORY TEST ABNORMAL 1 0.0000
432 PSYCHOTIC DISORDER 1 0.0000
433 RENAL INJURY 1 0.0000
434 DEVICE ISSUE 3 0.0000
435 BLOOD POTASSIUM DECREASED 1 0.0000
436 CORONARY ARTERY DISEASE 1 0.0000
437 SUICIDAL IDEATION 3 0.0000
438 ACUTE KIDNEY INJURY 5 0.0000
439 OVERDOSE 7 0.0000
440 OROPHARYNGEAL PAIN 3 0.0000
441 LIMB DISCOMFORT 1 0.0000
442 CARDIAC DISORDER 3 0.0000
443 SWOLLEN TONGUE 1 0.0000
444 DRUG-INDUCED LIVER INJURY 1 0.0000
445 HEAD INJURY 1 0.0000
446 CYSTITIS 1 0.0000
447 GAIT DISTURBANCE 6 0.0000
448 HYPOTHYROIDISM 1 0.0000
449 METABOLIC ACIDOSIS 1 0.0000
450 INTENTIONAL OVERDOSE 2 0.0000
451 NIGHT SWEATS 1 0.0000
452 RHINORRHOEA 2 0.0000
453 DEEP VEIN THROMBOSIS 2 0.0000
454 INCORRECT DOSE ADMINISTERED 7 0.0000
455 PAIN IN EXTREMITY 9 0.0000
456 NAUSEA 24 0.0000
457 VISUAL ACUITY REDUCED 1 0.0000
458 FALL 10 0.0000
459 SKIN DISORDER 1 0.0000
460 VOMITING 14 0.0000
461 TYPE 2 DIABETES MELLITUS 1 0.0000
462 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
463 SINUSITIS 3 0.0000
464 HAEMOGLOBIN DECREASED 3 0.0000
465 GASTRIC DISORDER 1 0.0000
466 DYSPNOEA 16 0.0000
467 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
468 ANXIETY 8 0.0000
469 PRODUCT ADHESION ISSUE 1 0.0000
470 CEREBRAL HAEMORRHAGE 1 0.0000
471 RESTLESSNESS 1 0.0000
472 DYSURIA 1 0.0000
473 NASOPHARYNGITIS 5 0.0000
474 BRONCHITIS 2 0.0000
475 DYSGEUSIA 2 0.0000
476 SEPSIS 3 0.0000
477 EPISTAXIS 2 0.0000
478 DYSPNOEA EXERTIONAL 1 0.0000
479 UNEVALUABLE EVENT 2 0.0000
480 ACNE 2 0.0000
481 BLOOD PRESSURE INCREASED 4 0.0000
482 HOSPITALISATION 4 0.0000
483 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
484 PALPITATIONS 3 0.0000
485 DISORIENTATION 1 0.0000
486 MALAISE 11 0.0000
487 INJECTION SITE BRUISING 2 0.0000
488 INJECTION SITE HAEMORRHAGE 2 0.0000
489 DRUG INEFFECTIVE 33 0.0000
490 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
491 DYSKINESIA 1 0.0000
492 LUNG NEOPLASM MALIGNANT 1 0.0000
493 OSTEOPOROSIS 1 0.0000
494 RENAL FAILURE ACUTE 1 0.0000
495 URINARY TRACT INFECTION 4 0.0000
496 HYPERHIDROSIS 3 0.0000
497 MENTAL DISORDER 1 0.0000
498 CONSTIPATION 5 0.0000
499 INTENTIONAL PRODUCT MISUSE 2 0.0000
500 COLITIS ULCERATIVE 1 0.0000
501 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
502 MUSCLE SPASMS 4 0.0000
503 SKIN DISCOLOURATION 1 0.0000
504 HYPOKALAEMIA 1 0.0000
505 DECREASED APPETITE 5 0.0000
506 WEIGHT DECREASED 6 0.0000
507 COGNITIVE DISORDER 1 0.0000
508 COUGH 6 0.0000
509 SWELLING 2 0.0000
510 COMA 1 0.0000
511 CONTUSION 2 0.0000
512 INTERSTITIAL LUNG DISEASE 1 0.0000
513 DYSPEPSIA 2 0.0000
514 HEART RATE INCREASED 2 0.0000
515 DRY EYE 1 0.0000
516 AGGRESSION 1 0.0000
517 CELLULITIS 1 0.0000
518 THERAPY CESSATION 1 0.0000
519 PERIPHERAL SWELLING 3 0.0000
520 FATIGUE 15 0.0000
521 ECZEMA 1 0.0000
522 MUSCULOSKELETAL PAIN 1 0.0000
523 BRADYCARDIA 1 0.0000
524 ASTHENIA 7 0.0000
525 DISTURBANCE IN ATTENTION 1 0.0000
526 PNEUMONIA 6 0.0000
527 OEDEMA 1 0.0000
528 TREATMENT NONCOMPLIANCE 1 0.0000
529 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
530 PRURITUS 7 0.0000
531 ANAPHYLACTIC REACTION 1 0.0000
532 TREMOR 3 0.0000
533 ARTHROPATHY 1 0.0000
534 MUSCULAR WEAKNESS 2 0.0000
535 LETHARGY 1 0.0000
536 SEIZURE 2 0.0000
537 COVID-19 3 0.0000
538 BONE PAIN 1 0.0000
539 WHEEZING 1 0.0000
540 CATARACT 1 0.0000
541 JOINT SWELLING 2 0.0000
542 SUICIDE ATTEMPT 1 0.0000
543 STOMATITIS 1 0.0000
544 OEDEMA PERIPHERAL 2 0.0000
545 VERTIGO 1 0.0000
546 DISCOMFORT 1 0.0000
547 FEELING HOT 1 0.0000
548 EXPOSURE DURING PREGNANCY 1 0.0000
549 RASH 7 0.0000
550 PRODUCT USE ISSUE 3 0.0000
551 DIARRHOEA 10 0.0000
552 SWELLING FACE 1 0.0000
553 PRODUCT DOSE OMISSION 1 0.0000
554 PSORIASIS 2 0.0000
555 ALOPECIA 3 0.0000
556 INFUSION RELATED REACTION 1 0.0000
557 FEBRILE NEUTROPENIA 1 0.0000
558 INSOMNIA 4 0.0000
559 DEHYDRATION 2 0.0000
560 DRY SKIN 2 0.0000
561 HYPOTENSION 3 0.0000
562 SOMNOLENCE 3 0.0000
563 HEPATIC ENZYME INCREASED 1 0.0000
564 ERYTHEMA 3 0.0000
565 VISION BLURRED 2 0.0000
566 INJECTION SITE REACTION 1 0.0000
567 DEVICE MALFUNCTION 1 0.0000
568 SLEEP DISORDER 1 0.0000
569 RESPIRATORY FAILURE 1 0.0000
570 UNDERDOSE 1 0.0000
571 AGITATION 1 0.0000
572 CARDIAC FAILURE 1 0.0000
573 CARDIAC FAILURE CONGESTIVE 1 0.0000
574 DRY MOUTH 1 0.0000
575 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
576 CARDIAC ARREST 1 0.0000
577 DRUG DOSE OMISSION 2 0.0000
578 DIZZINESS 6 0.0000
579 RENAL IMPAIRMENT 1 0.0000
580 SKIN EXFOLIATION 1 0.0000
581 MYOCARDIAL INFARCTION 2 0.0000
582 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
583 MUSCULOSKELETAL STIFFNESS 1 0.0000
584 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
585 GASTROINTESTINAL DISORDER 1 0.0000
586 NO ADVERSE EVENT 2 0.0000
587 ADVERSE EVENT 1 0.0000
588 HYPERSENSITIVITY 2 0.0000
589 NEUROPATHY PERIPHERAL 1 0.0000
590 SYNCOPE 1 0.0000
591 FLUSHING 1 0.0000
592 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
593 ILLNESS 1 0.0000
594 ABDOMINAL DISTENSION 1 0.0000
595 PLATELET COUNT DECREASED 1 0.0000
596 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
597 OFF LABEL USE 8 0.0000
598 INFLUENZA 1 0.0000
599 ASTHMA 1 0.0000
600 RHEUMATOID ARTHRITIS 1 0.0000
601 PYREXIA 3 0.0000
602 CHILLS 1 0.0000
603 VISUAL IMPAIRMENT 1 0.0000
604 NEUTROPENIA 1 0.0000
605 INFECTION 1 0.0000
606 CONDITION AGGRAVATED 2 0.0000
607 PARAESTHESIA 1 0.0000
608 DRUG INTERACTION 1 0.0000
609 CONFUSIONAL STATE 1 0.0000
610 URTICARIA 1 0.0000
611 MYALGIA 1 0.0000
612 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
613 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
614 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
615 DEATH 3 0.0000
616 PRODUCT DOSE OMISSION ISSUE 1 0.0000